Imaging Endpoints (IE) is a leading imaging research and core laboratory providing imaging CRO services for evaluating drug and device efficacy. The company's specialization lies in offering top-notch radiology expertise and advanced technologies, with a focus on conducting the largest and most complex trials in the industry.
Key Highlights:
Locations: Based in Scottsdale, AZ, Imaging Endpoints has offices in Waltham, MA, USA; Hyderabad, India; Leiden, Netherlands; Basel, Switzerland; London, UK; and Shanghai, China. Affiliates: The company is affiliated with HonorHealth, one of the largest healthcare systems nationally, and Scottsdale Medical Imaging, Ltd., a part of the largest private radiology group in the US. Deep Science: IE's Medical and Scientific Affairs Team comprises world-class leaders in imaging science, with over 50 publications in leading journals establishing them as a technology leader. Expert Readers: The team includes over 200 physician readers, with 40 in-house radiologists and academically based expert radiologists, oncologists, surgeons, and other physicians in the US. Global Services: IE is one of the largest global imaging CROs in oncology, receiving/reading scans in real-time from hundreds of imaging sites in over 35 countries. Quality Standards: The imaging Quality Management System (iQMS) exceeds industry standards, as evidenced by zero observations in all inspections by FDA and EMEA, demonstrating leadership in quality. Exceptional Stability: With a decade of high growth and no ownership or executive leadership change in over five years, IE presents strong stability.Founded in 2009, Imaging Endpoints operates within the Biotechnology, Health Care, and Pharmaceutical industries from its United States headquarters.
As of now, there is no publicly disclosed information about the last investment or related investors for Imaging Endpoints.